Jakub Tomasz Latos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jakub Tomasz Latos has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Katarzyna Anna Kowalska
Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, Łódź, Poland
11 shared publications - Adrianna Kaczmarek
10th Military Research Hospital and Polyclinic, Independent Public Healthcare Centre in Bydgoszcz, Bydgoszcz, Poland
10 shared publications - Franciszek Szweda
Władysław Biegański Regional Specialist Hospital in Grudziądz, Grudziądz, Poland
10 shared publications - Karolina Alicja Krystyniak
Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, Łódź, Poland
10 shared publications - Kinga Augustyniak
Independent Public Health Care Institution in Turek, Turek, Poland
10 shared publications - Marcin Chwalczuk
116th Military Hospital in Opole, Opole, Poland
10 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
PSYCHOSOMATIC SYMPTOMS IN ADULTS: PSYCHOLOGICAL AND SOCIAL DETERMINANTS
Psychosomatic symptoms constitute a significant health concern in contemporary society and are increasingly examined in the context of mental health and social functioning. The aim of this study was to present the psychological and social determinants of psychosomatic symptoms in adults based on current scientific literature. The article discusses the relationships between chronic stress, anxiety disorders, depression, and emotional difficulties and the occurrence of somatic symptoms without a clear organic basis. Particular attention was paid to the role of social factors, including occupational pressure, financial difficulties, social isolation, interpersonal conflicts, and the impact of modern lifestyles on the development of psychosomatic complaints. The analysis of available studies indicates that psychosomatic symptoms may include headaches, gastrointestinal complaints, palpitations, muscle tension, chronic fatigue, and sleep disturbances. Numerous studies have emphasized a strong association between the severity of psychosomatic symptoms and levels of anxiety, stress, and reduced psychological well-being. Mechanisms related to emotion regulation and individual psychological resilience were also found to play an important role. The findings of the literature review highlight the need for a holistic approach to the diagnosis and treatment of psychosomatic symptoms that considers both psychological and social aspects. The importance of mental health promotion, stress reduction strategies, and interventions aimed at improving quality of life among adults was also emphasized.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessPSYCHOSOMATIC SYMPTOMS IN ADULTS: PSYCHOLOGICAL AND SOCIAL DETERMINANTS
Psychosomatic symptoms constitute a significant health concern in contemporary society and are increasingly examined in the context of mental health and social functioning. The aim of this study was to present the psychological and social determinants of psychosomatic symptoms in adults based on current scientific literature. The article discusses the relationships between chronic stress, anxiety disorders, depression, and emotional difficulties and the occurrence of somatic symptoms without a clear organic basis. Particular attention was paid to the role of social factors, including occupational pressure, financial difficulties, social isolation, interpersonal conflicts, and the impact of modern lifestyles on the development of psychosomatic complaints. The analysis of available studies indicates that psychosomatic symptoms may include headaches, gastrointestinal complaints, palpitations, muscle tension, chronic fatigue, and sleep disturbances. Numerous studies have emphasized a strong association between the severity of psychosomatic symptoms and levels of anxiety, stress, and reduced psychological well-being. Mechanisms related to emotion regulation and individual psychological resilience were also found to play an important role. The findings of the literature review highlight the need for a holistic approach to the diagnosis and treatment of psychosomatic symptoms that considers both psychological and social aspects. The importance of mental health promotion, stress reduction strategies, and interventions aimed at improving quality of life among adults was also emphasized.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
THE ROLE OF STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE TREATMENT OF OLIGOMETASTATIC DISEASE – A CLINICAL REVIEW
Oligometastatic disease (OMD) is defined as an intermediate stage between localised cancer and widespread metastasis. The objective of this paper is to critically evaluate the clinical efficacy and safety of stereotactic ablative body radiation (SABR) in the treatment of OMD. This evaluation is based on a review of randomised trials from 2012 to 2025. A comprehensive analysis of pivotal clinical trials has revealed that the utilisation of ablation therapy is associated with a substantial enhancement in progression-free survival and overall survival, particularly in carefully selected patient populations. This assertion is corroborated by empirical evidence from studies conducted on prostate cancer (STOMP, ORIOLE) and specific subgroups of lung cancer (SINDAS). However, a discrepancy in outcomes was observed between patients receiving modern immunotherapy (NRG-LU002) and those treated for breast cancer (NRG-BR002), indicating a significant correlation between the efficacy of SABR and tumour biology, as well as the systemic treatment regimen employed. A thorough analysis of the existing evidence was conducted, encompassing the limitations arising from population heterogeneity, inadequate sample sizes in clinical trials, and the paucity of large-scale phase III trials for numerous histopathological types. The review also underscores the pivotal function of meticulous patient selection based on biomarkers, including circulating tumour DNA. The clinical findings suggest that SABR is a safe and highly effective method that allows for the deferral of toxic systemic treatment in selected patients. However, definitive standards for all subgroups will be established by ongoing phase III trials.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessTHE ROLE OF STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE TREATMENT OF OLIGOMETASTATIC DISEASE – A CLINICAL REVIEW
Oligometastatic disease (OMD) is defined as an intermediate stage between localised cancer and widespread metastasis. The objective of this paper is to critically evaluate the clinical efficacy and safety of stereotactic ablative body radiation (SABR) in the treatment of OMD. This evaluation is based on a review of randomised trials from 2012 to 2025. A comprehensive analysis of pivotal clinical trials has revealed that the utilisation of ablation therapy is associated with a substantial enhancement in progression-free survival and overall survival, particularly in carefully selected patient populations. This assertion is corroborated by empirical evidence from studies conducted on prostate cancer (STOMP, ORIOLE) and specific subgroups of lung cancer (SINDAS). However, a discrepancy in outcomes was observed between patients receiving modern immunotherapy (NRG-LU002) and those treated for breast cancer (NRG-BR002), indicating a significant correlation between the efficacy of SABR and tumour biology, as well as the systemic treatment regimen employed. A thorough analysis of the existing evidence was conducted, encompassing the limitations arising from population heterogeneity, inadequate sample sizes in clinical trials, and the paucity of large-scale phase III trials for numerous histopathological types. The review also underscores the pivotal function of meticulous patient selection based on biomarkers, including circulating tumour DNA. The clinical findings suggest that SABR is a safe and highly effective method that allows for the deferral of toxic systemic treatment in selected patients. However, definitive standards for all subgroups will be established by ongoing phase III trials.
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
MULTIFACTORIAL DETERMINANTS OF PRETERM BIRTH: A REVIEW OF CURRENT RISK FACTORS AND PREVENTIVE STRATEGIES
Preterm birth is one of the most serious challenges in modern perinatology, being a significant cause of morbidity and mortality in newborns and long-term health complications. PTB affects approximately 15,000,000 children worldwide each year and accounts for approximately 11% of births globally. It is responsible for a significant proportion of perinatal morbidity and mortality, as well as long-term neurological, metabolic, and developmental complications in children. The aim of this review was to summarize the current knowledge on the risk factors for preterm birth and to organize the most important ones. Preterm birth is a phenomenon with a complex etiology, and its risk results from the interaction of biological, obstetric, and environmental factors. The identification and modification of selected factors, especially those related to the mother's lifestyle and nutritional status, is a key element of prevention and prenatal care. Based on the available data, the clinical importance of early identification of risk factors and the implementation of preventive strategies and monitoring of high-risk pregnancies has been emphasized. A better understanding of the mechanisms leading to preterm birth may contribute to reducing the incidence of this complication and improving the prognosis for newborns.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessMULTIFACTORIAL DETERMINANTS OF PRETERM BIRTH: A REVIEW OF CURRENT RISK FACTORS AND PREVENTIVE STRATEGIES
Preterm birth is one of the most serious challenges in modern perinatology, being a significant cause of morbidity and mortality in newborns and long-term health complications. PTB affects approximately 15,000,000 children worldwide each year and accounts for approximately 11% of births globally. It is responsible for a significant proportion of perinatal morbidity and mortality, as well as long-term neurological, metabolic, and developmental complications in children. The aim of this review was to summarize the current knowledge on the risk factors for preterm birth and to organize the most important ones. Preterm birth is a phenomenon with a complex etiology, and its risk results from the interaction of biological, obstetric, and environmental factors. The identification and modification of selected factors, especially those related to the mother's lifestyle and nutritional status, is a key element of prevention and prenatal care. Based on the available data, the clinical importance of early identification of risk factors and the implementation of preventive strategies and monitoring of high-risk pregnancies has been emphasized. A better understanding of the mechanisms leading to preterm birth may contribute to reducing the incidence of this complication and improving the prognosis for newborns.
- Open Access
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
DIFFICULTIES IN TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD) – A REVIEW OF VARIOUS FORMS OF THERAPY AND PHARMACOLOGICAL METHODS
Objective: The primary objective of this comprehensive review is to systematically evaluate and synthesize the latest scientific knowledge regarding the pathophysiology, diagnostic complexities, and the clinical effectiveness of various therapeutic interventions for borderline personality disorder (BPD). Methods: A narrative literature review methodology was employed, involving a rigorous search of leading scientific databases, including PubMed, Scopus, Web of Science, and Google Scholar. The selection process prioritized randomized clinical trials, extensive meta-analyses, and current treatment guidelines, with a particular emphasis on peer-reviewed publications from the last decade to ensure the utmost relevance. Findings: A review of the literature indicates that integrated evidence-based psychotherapy, particularly dialectical behavior therapy (DBT) and mentalization-based treatment (MBT), remains the gold standard for treating BPD. Furthermore, intensive short-term forms (5–6 months) have been shown to be more clinically effective than traditional long-term programs. Pharmacotherapy plays exclusively a supportive role and is utilized for the temporary relief of acute symptoms. Second-generation antipsychotics (SGAs) are highly effective in mitigating suicidal behavior in severe cases of BPD. New biological interventions, such as intravenous ketamine infusions or the modulation of the newly studied gut-brain axis, represent highly promising areas of future research. Conclusions: Effective treatment of BPD requires a highly personalized, holistic approach, with psychotherapy serving as its undeniable foundation. Pharmacotherapy must be introduced with extreme caution, placing particular emphasis on the absolute avoidance of polypharmacy.
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessDIFFICULTIES IN TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD) – A REVIEW OF VARIOUS FORMS OF THERAPY AND PHARMACOLOGICAL METHODS
Objective: The primary objective of this comprehensive review is to systematically evaluate and synthesize the latest scientific knowledge regarding the pathophysiology, diagnostic complexities, and the clinical effectiveness of various therapeutic interventions for borderline personality disorder (BPD). Methods: A narrative literature review methodology was employed, involving a rigorous search of leading scientific databases, including PubMed, Scopus, Web of Science, and Google Scholar. The selection process prioritized randomized clinical trials, extensive meta-analyses, and current treatment guidelines, with a particular emphasis on peer-reviewed publications from the last decade to ensure the utmost relevance. Findings: A review of the literature indicates that integrated evidence-based psychotherapy, particularly dialectical behavior therapy (DBT) and mentalization-based treatment (MBT), remains the gold standard for treating BPD. Furthermore, intensive short-term forms (5–6 months) have been shown to be more clinically effective than traditional long-term programs. Pharmacotherapy plays exclusively a supportive role and is utilized for the temporary relief of acute symptoms. Second-generation antipsychotics (SGAs) are highly effective in mitigating suicidal behavior in severe cases of BPD. New biological interventions, such as intravenous ketamine infusions or the modulation of the newly studied gut-brain axis, represent highly promising areas of future research. Conclusions: Effective treatment of BPD requires a highly personalized, holistic approach, with psychotherapy serving as its undeniable foundation. Pharmacotherapy must be introduced with extreme caution, placing particular emphasis on the absolute avoidance of polypharmacy.
- Open Access
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
INVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION
Depression is a prevalent mental health disorder affecting approximately 4% of the global population. Pharmacological management commonly involves the use of serotonin–norepinephrine reuptake inhibitors (SNRIs), including venlafaxine, duloxetine, desvenlafaxine, milnacipran, and levomilnacipran. Although these agents are effective in alleviating depressive symptoms, their prolonged use raises concerns regarding long-term safety. Clinical guidelines recommend antidepressant (AD) therapy for at least six months following symptom remission after the first episode of major depression; however, in practice, treatment duration often extends for years. Extended exposure to SNRIs has been associated with both common short-term adverse effects—such as weight gain, appetite changes, and sexual dysfunction—and less understood long-term outcomes, including metabolic, cardiovascular, and skeletal complications. The objective of this study is to systematically evaluate existing literature on the long-term side effects of SNRI therapy in patients diagnosed with depression. By synthesizing current evidence, this review aims to enhance understanding of the risk profile associated with chronic SNRI use and inform safer clinical practices.
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessINVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION
Depression is a prevalent mental health disorder affecting approximately 4% of the global population. Pharmacological management commonly involves the use of serotonin–norepinephrine reuptake inhibitors (SNRIs), including venlafaxine, duloxetine, desvenlafaxine, milnacipran, and levomilnacipran. Although these agents are effective in alleviating depressive symptoms, their prolonged use raises concerns regarding long-term safety. Clinical guidelines recommend antidepressant (AD) therapy for at least six months following symptom remission after the first episode of major depression; however, in practice, treatment duration often extends for years. Extended exposure to SNRIs has been associated with both common short-term adverse effects—such as weight gain, appetite changes, and sexual dysfunction—and less understood long-term outcomes, including metabolic, cardiovascular, and skeletal complications. The objective of this study is to systematically evaluate existing literature on the long-term side effects of SNRI therapy in patients diagnosed with depression. By synthesizing current evidence, this review aims to enhance understanding of the risk profile associated with chronic SNRI use and inform safer clinical practices.
- Open Access
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
LITHIUM AND ALZHEIMER’S DISEASE: NEUROBIOLOGICAL MECHANISMS, ETHICAL IMPLICATIONS, AND SOCIAL PERSPECTIVES ON COGNITIVE AGING
Alzheimer’s disease is a progressive, idiopathic neurodegenerative disorder characterized by the accumulation of amyloid plaques, tau tangles, and synaptic degeneration. Its global prevalence continues to rise, posing significant challenges for healthcare systems and aging societies. Despite recent advances in disease-modifying treatment, such as monoclonal antibodies (donanemab, lecanemab, aducanumab), their high cost, limited efficacy, and risk of adverse effects underline the urgent need for therapies that are safe, effective, and economically accessible. This review evaluates the role of lithium a long-established mood stabilizer in the prevention and modulation of Alzheimer’s disease. Drawing from preclinical studies, observational data, and early-phase clinical trials published between 2017 and 2025, it examines how lithium influences key pathological mechanisms including amyloid precursor protein processing, tau phosphorylation, oxidative stress, neuroinflammation, and synaptic plasticity. Chronic exposure to low or trace doses has been associated with delayed cognitive decline and reduced disease incidence in several populations. However, evidence from randomized trials remains inconclusive, warranting further rigorous investigation. In addition to biological mechanisms, this review explores ethical and social dimensions of lithium use in older adults, including questions of informed consent, adherence, age-related pharmacokinetics, and the stigma of psychiatric medication. Lithium emerges as a biologically plausible, cost-effective, and potentially scalable strategy for addressing cognitive aging. Future directions require ethically sound, large-scale clinical trials and a broader public health dialogue on the integration of preventive pharmacotherapy into neurodegenerative disease management.
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessLITHIUM AND ALZHEIMER’S DISEASE: NEUROBIOLOGICAL MECHANISMS, ETHICAL IMPLICATIONS, AND SOCIAL PERSPECTIVES ON COGNITIVE AGING
Alzheimer’s disease is a progressive, idiopathic neurodegenerative disorder characterized by the accumulation of amyloid plaques, tau tangles, and synaptic degeneration. Its global prevalence continues to rise, posing significant challenges for healthcare systems and aging societies. Despite recent advances in disease-modifying treatment, such as monoclonal antibodies (donanemab, lecanemab, aducanumab), their high cost, limited efficacy, and risk of adverse effects underline the urgent need for therapies that are safe, effective, and economically accessible. This review evaluates the role of lithium a long-established mood stabilizer in the prevention and modulation of Alzheimer’s disease. Drawing from preclinical studies, observational data, and early-phase clinical trials published between 2017 and 2025, it examines how lithium influences key pathological mechanisms including amyloid precursor protein processing, tau phosphorylation, oxidative stress, neuroinflammation, and synaptic plasticity. Chronic exposure to low or trace doses has been associated with delayed cognitive decline and reduced disease incidence in several populations. However, evidence from randomized trials remains inconclusive, warranting further rigorous investigation. In addition to biological mechanisms, this review explores ethical and social dimensions of lithium use in older adults, including questions of informed consent, adherence, age-related pharmacokinetics, and the stigma of psychiatric medication. Lithium emerges as a biologically plausible, cost-effective, and potentially scalable strategy for addressing cognitive aging. Future directions require ethically sound, large-scale clinical trials and a broader public health dialogue on the integration of preventive pharmacotherapy into neurodegenerative disease management.
- Open Access
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
PREVENTION OF SURGICAL SITE INFECTIONS: A COMPREHENSIVE REVIEW OF GUIDELINES AND SCIENTIFIC EVIDENCE (2017–2025)
Surgical site infections (SSIs) remain one of the most significant challenges in modern medicine, representing a major cause of patient morbidity, prolonged hospitalization, and increased healthcare costs in medical institutions. This issue deserves particular attention due to the possibility of preventing adverse outcomes through the implementation of standardized, evidence-based preventive measures approved by international health authorities. This narrative review examines recommendations aimed at reducing the incidence of SSIs based on publications indexed in major scientific databases, along with guidelines issued by the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and the National Institute for Health and Care Excellence (NICE). The article focuses on perioperative recommendations, categorized as preoperative, intraoperative, and postoperative, while considering both the strength of evidence and areas of consistency or divergence among these guidelines. Researchers worldwide generally agree on the most essential preventive strategies, including proper timing of antimicrobial prophylaxis, the use of chlorhexidine-based antiseptics, maintenance of normothermia and glycemic control, and avoidance of unnecessary hair removal. However, differences persist in certain preventive components, such as the use of advanced wound dressings, intraoperative oxygen supplementation, and mechanical barriers, highlighting the need for further discussion and harmonization of global standards. The review emphasizes the importance of implementing these guidelines in clinical practice and identifies unresolved issues requiring additional research. Strengthening education among healthcare professionals and ensuring adherence to correct perioperative practices under expert supervision will undoubtedly contribute to improved surgical outcomes and reduced infection-related complications worldwide.
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessPREVENTION OF SURGICAL SITE INFECTIONS: A COMPREHENSIVE REVIEW OF GUIDELINES AND SCIENTIFIC EVIDENCE (2017–2025)
Surgical site infections (SSIs) remain one of the most significant challenges in modern medicine, representing a major cause of patient morbidity, prolonged hospitalization, and increased healthcare costs in medical institutions. This issue deserves particular attention due to the possibility of preventing adverse outcomes through the implementation of standardized, evidence-based preventive measures approved by international health authorities. This narrative review examines recommendations aimed at reducing the incidence of SSIs based on publications indexed in major scientific databases, along with guidelines issued by the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and the National Institute for Health and Care Excellence (NICE). The article focuses on perioperative recommendations, categorized as preoperative, intraoperative, and postoperative, while considering both the strength of evidence and areas of consistency or divergence among these guidelines. Researchers worldwide generally agree on the most essential preventive strategies, including proper timing of antimicrobial prophylaxis, the use of chlorhexidine-based antiseptics, maintenance of normothermia and glycemic control, and avoidance of unnecessary hair removal. However, differences persist in certain preventive components, such as the use of advanced wound dressings, intraoperative oxygen supplementation, and mechanical barriers, highlighting the need for further discussion and harmonization of global standards. The review emphasizes the importance of implementing these guidelines in clinical practice and identifies unresolved issues requiring additional research. Strengthening education among healthcare professionals and ensuring adherence to correct perioperative practices under expert supervision will undoubtedly contribute to improved surgical outcomes and reduced infection-related complications worldwide.
- Open Access
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
THE IMPACT OF CHRONIC CANNABINOID USE AND DEPENDENCE ON OPIOID ANALGESIC TREATMENT – A SYSTEMATIC REVIEW AND PREDICTIVE ANALYSIS
In recent years, there has been growing interest in cannabinoids as potential analgesics and alternatives to opioids. Cannabinoids, through modulation of the endocannabinoid system, affect nerve transmission, neuroplasticity, and inflammatory processes, and their action on CB1 and CB2 receptors is similar to the mechanisms of the opioid system, in particular μ, δ, and κ receptors. The aim of this study was to compare the mechanisms of action of cannabinoids and opioids, review studies on their combined use, and assess the impact of chronic cannabinoid use and dependence on the effectiveness of opioid-based pain treatment. Analysis of the available data showed that moderate use of cannabinoids, especially preparations with a balanced THC and CBD content, can lead to an "opioid-sparing" effect, allowing opioid doses to be reduced without losing the analgesic effect. However, chronic use of cannabinoids, especially those with high THC content, is associated with the development of tolerance, mood disorders, desensitization of CB1 receptors, and disturbances in the co-regulation of μ receptors, which may lead to compensatory escalation of opioid treatment and the development of cross-addiction. In addition, partial clinical benefits have been observed in patients with neuropathic pain from the combination of cannabinoid and opioid therapy, while no clear analgesic effects have been observed in acute pain. The proposed predictive model integrates molecular, clinical, and psychological aspects, indicating that the effectiveness of analgesic therapy depends on the duration of exposure to cannabinoids, the type of pain, and the individual predisposition of the patient. The authors point to the need for further research involving patients who are chronic users of cannabinoids or addicted to them and who are scheduled to be treated with opioids. The results of such analyses could form the basis for the development of clinical guidelines for integrated pain therapy that minimizes the risk of addiction and treatment failure.
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessTHE IMPACT OF CHRONIC CANNABINOID USE AND DEPENDENCE ON OPIOID ANALGESIC TREATMENT – A SYSTEMATIC REVIEW AND PREDICTIVE ANALYSIS
In recent years, there has been growing interest in cannabinoids as potential analgesics and alternatives to opioids. Cannabinoids, through modulation of the endocannabinoid system, affect nerve transmission, neuroplasticity, and inflammatory processes, and their action on CB1 and CB2 receptors is similar to the mechanisms of the opioid system, in particular μ, δ, and κ receptors. The aim of this study was to compare the mechanisms of action of cannabinoids and opioids, review studies on their combined use, and assess the impact of chronic cannabinoid use and dependence on the effectiveness of opioid-based pain treatment. Analysis of the available data showed that moderate use of cannabinoids, especially preparations with a balanced THC and CBD content, can lead to an "opioid-sparing" effect, allowing opioid doses to be reduced without losing the analgesic effect. However, chronic use of cannabinoids, especially those with high THC content, is associated with the development of tolerance, mood disorders, desensitization of CB1 receptors, and disturbances in the co-regulation of μ receptors, which may lead to compensatory escalation of opioid treatment and the development of cross-addiction. In addition, partial clinical benefits have been observed in patients with neuropathic pain from the combination of cannabinoid and opioid therapy, while no clear analgesic effects have been observed in acute pain. The proposed predictive model integrates molecular, clinical, and psychological aspects, indicating that the effectiveness of analgesic therapy depends on the duration of exposure to cannabinoids, the type of pain, and the individual predisposition of the patient. The authors point to the need for further research involving patients who are chronic users of cannabinoids or addicted to them and who are scheduled to be treated with opioids. The results of such analyses could form the basis for the development of clinical guidelines for integrated pain therapy that minimizes the risk of addiction and treatment failure.
- Open Access
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
COMPARATIVE EFFECTIVENESS OF PAIN-RELIEF METHODS DURING LABOUR: A LITERATURE REVIEW
Effective management of labour and childbirth pain is one of the goals of modern obstetric care. This review compares the effectiveness of pharmacological and non-pharmacological methods of pain relief during labour and childbirth, based on recent randomized controlled trials, meta-analyses, and systematic reviews. Epidural and combined spinal-epidural techniques provide the most profound and reliable pain relief with high maternal satisfaction, although they prolong the second stage of labour and require specialist monitoring. Systemic opioids – pethidine, fentanyl, and remifentanil – offer moderate analgesia; updated remifentanil protocols have improved safety and maternal autonomy where neuraxial services are limited. Nitrous oxide remains a safe, reversible alternative with limited efficacy. Among non-pharmacological methods, evidence supports hydrotherapy, massage, acupuncture, acupressure, transcutaneous electrical nerve stimulation (TENS), relaxation and breathing techniques, and continuous emotional support. Emerging data highlight the benefits of sterile water injections for lower-back pain, as well as music therapy, mindfulness, virtual reality, peanut-ball positioning, aromatherapy, and thermal therapy as safe and complementary methods of relieving labour pain. These methods enhance maternal comfort and satisfaction and reduce anxiety and perceived pain intensity. Comparative evidence confirms that no single intervention is universally superior. A multimodal, individualized approach that integrates pharmacological precision with supportive, behavioural, and sensory-based techniques offers the most effective pathway for improving maternal experience during labour.
- 16 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessCOMPARATIVE EFFECTIVENESS OF PAIN-RELIEF METHODS DURING LABOUR: A LITERATURE REVIEW
Effective management of labour and childbirth pain is one of the goals of modern obstetric care. This review compares the effectiveness of pharmacological and non-pharmacological methods of pain relief during labour and childbirth, based on recent randomized controlled trials, meta-analyses, and systematic reviews. Epidural and combined spinal-epidural techniques provide the most profound and reliable pain relief with high maternal satisfaction, although they prolong the second stage of labour and require specialist monitoring. Systemic opioids – pethidine, fentanyl, and remifentanil – offer moderate analgesia; updated remifentanil protocols have improved safety and maternal autonomy where neuraxial services are limited. Nitrous oxide remains a safe, reversible alternative with limited efficacy. Among non-pharmacological methods, evidence supports hydrotherapy, massage, acupuncture, acupressure, transcutaneous electrical nerve stimulation (TENS), relaxation and breathing techniques, and continuous emotional support. Emerging data highlight the benefits of sterile water injections for lower-back pain, as well as music therapy, mindfulness, virtual reality, peanut-ball positioning, aromatherapy, and thermal therapy as safe and complementary methods of relieving labour pain. These methods enhance maternal comfort and satisfaction and reduce anxiety and perceived pain intensity. Comparative evidence confirms that no single intervention is universally superior. A multimodal, individualized approach that integrates pharmacological precision with supportive, behavioural, and sensory-based techniques offers the most effective pathway for improving maternal experience during labour.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
Isotretinoin (13-cis-retinoic acid) remains the most effective systemic therapy for severe acne, exerting its therapeutic action through modulation of retinoic acid (RAR) and retinoid X (RXR) receptors that regulate cell differentiation, apoptosis, and lipid metabolism. However, these same receptor-mediated pathways underlie a range of multisystem adverse effects. This review provides an updated synthesis of isotretinoin’s systemic toxicity profile, focusing on mechanistic insights and clinical relevance. Mucocutaneous reactions such as cheilitis and xerosis are the most frequent and predictable effects, reflecting sebaceous suppression. Hepatic enzyme elevations and dyslipidemia occur in a dose-dependent yet reversible manner, necessitating routine laboratory surveillance. Musculoskeletal, ocular, and neuropsychiatric effects are infrequent, generally mild, and self-limiting, though psychiatric monitoring remains advisable in predisposed individuals. Gastrointestinal and endocrine disturbances, including subclinical hypothyroidism, have been reported but lack strong causal evidence. Hematologic and renal alterations are minor and transient. The most critical safety concern remains isotretinoin’s potent teratogenicity, emphasizing the need for strict contraceptive protocols and post-therapy washout periods. Overall, isotretinoin’s adverse effects largely reflect its pharmacodynamic actions and are manageable through individualized dosing and systematic monitoring. Understanding the mechanisms and risk factors underlying these reactions is essential for optimizing therapeutic safety and patient outcomes.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessMULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
Isotretinoin (13-cis-retinoic acid) remains the most effective systemic therapy for severe acne, exerting its therapeutic action through modulation of retinoic acid (RAR) and retinoid X (RXR) receptors that regulate cell differentiation, apoptosis, and lipid metabolism. However, these same receptor-mediated pathways underlie a range of multisystem adverse effects. This review provides an updated synthesis of isotretinoin’s systemic toxicity profile, focusing on mechanistic insights and clinical relevance. Mucocutaneous reactions such as cheilitis and xerosis are the most frequent and predictable effects, reflecting sebaceous suppression. Hepatic enzyme elevations and dyslipidemia occur in a dose-dependent yet reversible manner, necessitating routine laboratory surveillance. Musculoskeletal, ocular, and neuropsychiatric effects are infrequent, generally mild, and self-limiting, though psychiatric monitoring remains advisable in predisposed individuals. Gastrointestinal and endocrine disturbances, including subclinical hypothyroidism, have been reported but lack strong causal evidence. Hematologic and renal alterations are minor and transient. The most critical safety concern remains isotretinoin’s potent teratogenicity, emphasizing the need for strict contraceptive protocols and post-therapy washout periods. Overall, isotretinoin’s adverse effects largely reflect its pharmacodynamic actions and are manageable through individualized dosing and systematic monitoring. Understanding the mechanisms and risk factors underlying these reactions is essential for optimizing therapeutic safety and patient outcomes.